Cargando…

Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis

BACKGROUND: This Bayesian network meta-analysis (NMA) was conducted to compare efficacy and safety of programmed death 1/ligand 1 (PD-1/L1) inhibitors in previous untreated advanced non-small cell lung cancer (NSCLC) patients. METHODS: Eligible studies evaluating first-line anti-PD-1/L1 based regime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Hengrui, Lin, Guo, Wang, Wei, Huang, Jun, Yang, Yilin, Lan, Yuting, Wang, Runchen, Cui, Fei, Hao, Zhexue, Deng, Hongsheng, Zhao, Shen, Cheng, Bo, Xiong, Shan, Li, Jianfu, Li, Caichen, Liu, Jun, He, Jianxing, Liang, Wenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225152/ https://www.ncbi.nlm.nih.gov/pubmed/32420059 http://dx.doi.org/10.21037/tlcr.2020.02.14

Ejemplares similares

Management for Residual Ground-Glass Opacity Lesions After Resection of Main Tumor in Multifocal Lung Cancer: A Case Report and Literature Review
por: Cheng, Bo, et al.
Publicado: (2021)

Aspirin and risk of different cancers: an umbrella meta-analysis
por: Jiang, Yu, et al.
Publicado: (2020)

The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer
por: Cheng, Bo, et al.
Publicado: (2021)

Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers
por: Deng, Hongsheng, et al.
Publicado: (2022)

Identifying optimal candidates for primary tumor resection among metastatic non-small cell lung cancer patients: a population-based predictive model
por: Liang, Hengrui, et al.
Publicado: (2021)

Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
por: Li, Caichen, et al.
Publicado: (2020)

PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China
por: Li, Caichen, et al.
Publicado: (2020)

Prognostic and predictive impact of creatine kinase level in non-small cell lung cancer treated with tyrosine kinase inhibitors
por: Jiang, Yu, et al.
Publicado: (2021)

Genetically predicted bipolar disorder is causally associated with an increased risk of breast cancer: a two-sample Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2021)

An annual review of the remarkable advances in lung cancer clinical research in 2019
por: Cheng, Bo, et al.
Publicado: (2020)

Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
por: Liang, Hengrui, et al.
Publicado: (2020)

Nomogram for predicting the survival rate of primary pulmonary mucoepidermoid carcinoma patients: a retrospective study based on SEER database
por: Lin, Guo, et al.
Publicado: (2021)

Thoracic surgery and COVID-19: changes and managements during the pandemic
por: Wang, Runchen, et al.
Publicado: (2021)

Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts
por: Ge, Fan, et al.
Publicado: (2020)

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
por: Liang, Wenhua, et al.
Publicado: (2020)

Spontaneous ventilation video-assisted thoracic surgery for mediastinal tumor resection in patients with pulmonary function deficiency
por: Huang, Weizhe, et al.
Publicado: (2020)

Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts
por: Ge, Fan, et al.
Publicado: (2021)

Lung cancers and pulmonary nodules detected by computed tomography scan: a population-level analysis of screening cohorts
por: Li, Caichen, et al.
Publicado: (2021)

“Major pathologic response” in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy
por: Deng, Hongsheng, et al.
Publicado: (2023)

Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study
por: Feng, Yi, et al.
Publicado: (2022)

Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database
por: Xiong, Shan, et al.
Publicado: (2023)

Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report
por: Chen, Zhuxing, et al.
Publicado: (2021)

Association between systemic lupus erythematosus and lung cancer: results from a pool of cohort studies and Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2020)

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations
por: Jiang, Yu, et al.
Publicado: (2023)

Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer
por: Zheng, Jianqi, et al.
Publicado: (2021)

DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model
por: Chen, Zisheng, et al.
Publicado: (2020)

Comparison of different surgical approaches for anterior mediastinal tumor
por: Mao, Yong, et al.
Publicado: (2020)

Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies
por: Huo, Zhenyu, et al.
Publicado: (2020)

Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
por: Hao, Zhexue, et al.
Publicado: (2021)

Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
por: He, Qihua, et al.
Publicado: (2021)

Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy
por: Chen, Zhuxing, et al.
Publicado: (2022)

Age at first birth and lung cancer: a two-sample Mendelian randomization study
por: Peng, Haoxin, et al.
Publicado: (2021)

The safety of first and subsequent lines of PD-1/PD-L1 inhibitors monotherapy in non-small cell lung cancer patients: a meta-analysis
por: Yang, Yilin, et al.
Publicado: (2020)

Univariable and Multivariable Two-Sample Mendelian Randomization Investigating the Effects of Leisure Sedentary Behaviors on the Risk of Lung Cancer
por: Peng, Haoxin, et al.
Publicado: (2021)

Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer: A Systematic Review and Meta-analysis
por: Ge, Fan, et al.
Publicado: (2022)

Concealed driver in lung adenocarcinoma with single PIK3CA mutation: a case report and single-center genotyping review
por: Zhu, Feng, et al.
Publicado: (2021)

Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer
por: Liang, Hengrui, et al.
Publicado: (2021)

Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer
por: Wu, Xiangrong, et al.
Publicado: (2022)

Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2022)

The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
por: Li, Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ulhrus1lg7kakrelsn5g5knne2